Rezon Bio Launches Two State-of-the-Art CDMO Facilities for Biologics in Europe on September 29, 2025 Biological Factors CDMO Contract agreement Digital innovation Europe Gdańsk Guanosine Monophosphate manufacturing Rezon Bio Warsaw-Duchnice +
Celltrion Acquires Eli Lilly’s New Jersey Manufacturing Site for $330 Million on September 23, 2025 Acquisition biopharmaceutical manufacturing Biosimilars Celltrion Contract agreement Eli Lilly Investments Jersey site supply chain US tariffs +
AstraZeneca Ends Manufacturing License at Indian Plant and Exits Site as Part of Global Strategy on September 04, 2025 AstraZeneca Bangalore plant Contract agreement Drug Industry global strategy India manufacturing manufacturing license Site of exit +
HHS ousts MAHA implementation lead amid rushed cancellations of $500M in mRNA vaccine contracts on August 11, 2025 BARDA CHARGE Syndrome Contract agreement Gray Delany MAHA Moderna mRNA contracts Pfizer Policy Robert F. Kennedy Seqirus Shakeup SMPX gene Staff terminations Vaccines +
Viking Therapeutics Signs $150 Million Manufacturing Deal with CordenPharma for Obesity Drug VK2735 on March 12, 2025 alpha 1-antitrypsin Capacity Contract agreement CordenPharma Fill/finish GLP-1/GIP dual agonist Obesity oral formulations production subcutaneous Viking VK2735 +
Fierce Pharma AsiaAstellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract on March 10, 2025 Contract agreement first IGA Glomerulonephritis Samsung Sibeprenlimab United States Food and Drug Administration +
Johnson & Johnson Sues Samsung Bioepis Over Alleged Stelara Biosimilar Contract Breach on February 27, 2025 Bioepis Biosimilars Contract agreement Johnson and Johnson Pyzchiva Samsung Stelara ustekinumab +